C Swaminatha Mudaliar Sons and Co – Trademark Portfolio

Entity Type: 03

C Swaminatha Mudaliar Sons and Co holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. The owner is based in Madurai, Tamilnadu.

9/205 Natham Main Road, Manthikulam

Madurai, Tamilnadu 625014 , IN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SANATEQ
SANATEQ
Abandoned 2025
SNTQ
SNTQ
Abandoned 2025

Trademark Classifications

C Swaminatha Mudaliar Sons and Co's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does C Swaminatha Mudaliar Sons and Co have?

C Swaminatha Mudaliar Sons and Co has 3 U.S. trademarks filed with the USPTO.

What trademark classes does C Swaminatha Mudaliar Sons and Co file in?

C Swaminatha Mudaliar Sons and Co files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 25 (Clothing), Class 20 (Furniture). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is C Swaminatha Mudaliar Sons and Co's trademark registration success rate?

C Swaminatha Mudaliar Sons and Co has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.